Origin Materials (ORGN)
(Delayed Data from NSDQ)
$0.91 USD
-0.01 (-1.20%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $0.91 0.00 (-0.47%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$0.91 USD
-0.01 (-1.20%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $0.91 0.00 (-0.47%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Zacks News
Origin Materials, Inc. (ORGN) Loses -66.27% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
Origin Materials, Inc. (ORGN) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Origin Materials, Inc. (ORGN) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
Origin Materials, Inc. (ORGN) delivered earnings and revenue surprises of 35.71% and 25.02%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
What Makes Origin Materials, Inc. (ORGN) a New Buy Stock
by Zacks Equity Research
Origin Materials, Inc. (ORGN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).